Ronald J. Daniels, Director at BridgeBio Pharma, Inc. (BBIO), sold 122,062 shares at $63.72 ($7.8M) on 2025-11-06, disclosed to the SEC on 2025-11-07.
Open-market sale of $7.8M BBIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.72 | 61,031 | $3.9M | 50.0% |
| 2 | $63.72 | 61,031 | $3.9M | 50.0% |
| Total | $63.72 avg | 122,062 | $7.8M | 100% |
| Filing → |